Aventura, Florida
Alzheimer's disease clinical trials in Aventura, FL
8 Alzheimer's disease studies are recruiting participants at sites in Aventura as of November 16, 2026, according to ClinicalTrials.gov. Clinical Trials for Alzheimer's Disease can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Aventura at a glance
- 8 studies are recruiting at a site in Aventura.
- By phase: Phase 2 (2), Phase 2/3 (1), Phase 3 (3), Phase 4 (1), Observational (1).
- By sponsor: industry (8).
- Most recent update to one of these records: November 5, 2026.
Studies recruiting in Aventura
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
ACP-204 in Adults With Alzheimer's Disease Psychosis
- Phase 2/3
- Ages 55 to 95
- All sexes
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Study site
- Humanity Clinical Research Corp
- Registry record
- NCT06159673 · updated
Flutemetamol F 18 Injection Formulation Comparison
- Phase 2
- Ages 50 to 110
- All sexes
- Sponsor
- GE Healthcare
- Study site
- Visionary Investigator Network
- Registry record
- NCT07873463 · updated
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- Phase 2
- Ages 55 to 85
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- VIN - Aventura
- Registry record
- NCT07589595 · updated
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- Phase 3
- Ages 55 to 90
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- Visionary Investigators Network
- Registry record
- NCT07011745 · updated
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Phase 3
- Ages 55 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- VIN - Aventura
- Registry record
- NCT07602582 · updated
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Phase 3
- Ages 60 to 85
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- VIN-Julie Schwartzbard
- Registry record
- NCT06976216 · updated
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
- Phase 4
- Ages 50 and older
- All sexes
- Sponsor
- Alpha Cognition, Inc
- Study site
- First Choice Neurology - Aventura Neurologic Associates
- Registry record
- NCT07633470 · updated
Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
- Observational
- Ages 60 to 90
- All sexes
- Sponsor
- GAP Innovations, PBC
- Study site
- Visionary Investigators Network
- Registry record
- NCT06584357 · updated
Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in Aventura, FL on ClinicalTrials.gov.
Ask about studies near Aventura
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Florida
All Florida locations
61 studies recruiting across 50 cities.
Miami
24 studies recruiting.
Tampa
20 studies recruiting.
Maitland
19 studies recruiting.
Orlando
19 studies recruiting.
Winter Park
11 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Clinical Trials for Alzheimer's Disease does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections